Brainstorm Cell Therapeutics (BCLI) Reschedules Conf. Call Due to Longer-than-Expected Embargo
Tweet Send to a Friend
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) announced that it has rescheduled its conference call, originally scheduled for Wednesday, December 16 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
